Related Experiment Videos
The "n-1" model for myelodysplastic syndromes
L Luzzatto1, F Colonna, I Reilly
1Department of Haematology, Hammersmith Hospital Royal Postgraduate Medical School, London, U.K.
Leukemia Research
|January 1, 1992
Summary
Researchers explored leukaemogenesis by targeting pre-leukaemic cells. They successfully transfected human bone marrow cells with a retrovirus, demonstrating a potential step towards understanding leukaemia development.
Area of Science:
- Hematology
- Molecular Biology
- Oncology
Background:
- Leukaemogenesis models propose a multi-step process.
- Myelodysplastic syndromes (MDS) are recognized as pre-leukaemic disorders.
- Pre-leukaemic cells ('n-1' cells) are hypothesized to exist in MDS bone marrow.
Purpose of the Study:
- To investigate the potential for in vitro leukaemic transformation of pre-leukaemic cells.
- To test the feasibility of introducing leukaemogenic genes into MDS-derived cells.
- To establish a model system for studying early steps in leukaemogenesis.
Main Methods:
- Utilized a retroviral vector (VSN-2) carrying the neomycin-phosphotransferase (neo) gene.
- Transfected human bone marrow cells in microcultures.
- Selected for G418-resistant cells, indicative of successful transfection.
Main Results:
- Successfully transfected human bone marrow cells.
- Recovered G418-resistant colony-forming unit-culture medium (CFU-CM) for several weeks.
- Demonstrated the viability of using retroviral gene transfer in this model system.
Conclusions:
- Human bone marrow cells can be successfully transfected in vitro.
- This approach provides a model for studying leukaemogenesis.
- Further research can explore specific leukaemogenic mutations in 'n-1' cells.